arrow
A

Alessandra Renieri

University of Siena
H指数:72
被引数:3.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trop-1/EpCAM Thr115 is a driver of hyperproliferative cell repair and of severe lung damage in COVID-19

Trop-1/EpCAM Thr115是COVID-19中细胞过度增殖修复和严重肺损伤的驱动因素

2026-09-010
OAAI
A Complex Case of Retinoblastoma Solved by the Combined Approach of Humor/Plasma cfDNA-NGS and LR-WGS

视网膜母细胞瘤的复杂病例通过Humor/Plasma cfDNA-NGS与LR-WGS的联合方法得到解决

2025-11-220
OAAI
Oxford Nanopore Technologies [ONT] Sequencing: Clinical Validation in Genetically Heterogeneous Disorders

Oxford Nanopore Technologies [ONT]测序:遗传异质性疾病的临床验证

2025-11-030
OAAI
Validation of the NovaSeq6000 Platform and automated library preparation for CE-IVD equivalence

NovaSeq6000平台的验证及用于CE-IVD等效性的自动化文库制备

2025-11-010
OAAI
Genetic modifiers and ascertainment drive variable expressivity of complex disorders

遗传修饰因子和病例发现方式驱动复杂疾病的表型可变性

Cell
IF42.5
2025-10-070
OAAI
Limited overlap between genetic effects on disease susceptibility and disease survival

遗传因素对疾病易感性和疾病生存影响的有限重叠

2025-09-300
OAAI
Attenuated Clinical Forms of Tubulinopathies in Children and Adults: A Series of 24 Individuals

微弱型微管病在儿童和成人中的临床表现:24例病例系列研究

2025-06-110
OA
Genotype-phenotype correlations and clinical outcomes of genetic TRPC6 podocytopathies

基因型-表型相关性及遗传性TRPC6足细胞病变的临床结局

2025-06-010
PRE
Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response
2024-04-041
OA
Elucidating the clinical and molecular spectrum of SMARCC2-associated NDD in a cohort of 65 affected individuals
2023-11-014
OAAI
CYP19A1 mediates severe SARS-CoV-2 disease outcome in males

CYP19A1介导男性严重SARS-CoV-2疾病转归

2023-09-017
OAAI
YWHAE loss of function causes a rare neurodevelopmental disease with brain abnormalities in human and mouse
2023-07-012
OA
Positive Predictive Values and Outcomes for Uninformative Cell-Free DNA Tests: An Italian Multicentric Cytogenetic and Cytogenomic Audit of DiagnOstic Testing (ICARO Study)
2023-06-010
OA